Concerns growing over government’s price cut

There are mounting concerns over the government’s pressure to lower drug costs, although some large pharmaceutical firms, such as Yuhan Corporation, Hanmi Pharm, Green Cross Corporation and Chong Kun Dang Pharmaceutical fared well in terms of revenues and net incomes last year.

These firms saw their last year’s sales growth increasing up to 18 percent on average from the previous year, with...